Mesa Laboratories Statistics
Total Valuation
MLAB has a market cap or net worth of $490.60 million. The enterprise value is $642.25 million.
| Market Cap | 490.60M |
| Enterprise Value | 642.25M |
Important Dates
The last earnings date was Tuesday, February 3, 2026, before market open.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Feb 27, 2026 |
Share Statistics
MLAB has 5.52 million shares outstanding. The number of shares has increased by 1.51% in one year.
| Current Share Class | 5.52M |
| Shares Outstanding | 5.52M |
| Shares Change (YoY) | +1.51% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 3.22% |
| Owned by Institutions (%) | 85.76% |
| Float | 5.03M |
Valuation Ratios
The trailing PE ratio is 130.54 and the forward PE ratio is 64.04.
| PE Ratio | 130.54 |
| Forward PE | 64.04 |
| PS Ratio | 2.03 |
| Forward PS | 1.90 |
| PB Ratio | 2.62 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.25 |
| P/OCF Ratio | 12.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.20, with an EV/FCF ratio of 16.93.
| EV / Earnings | 172.00 |
| EV / Sales | 2.59 |
| EV / EBITDA | 15.20 |
| EV / EBIT | 37.27 |
| EV / FCF | 16.93 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.91.
| Current Ratio | 1.94 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 3.48 |
| Debt / FCF | 4.48 |
| Interest Coverage | 1.62 |
Financial Efficiency
Return on equity (ROE) is 2.18% and return on invested capital (ROIC) is 1.38%.
| Return on Equity (ROE) | 2.18% |
| Return on Assets (ROA) | 2.47% |
| Return on Invested Capital (ROIC) | 1.38% |
| Return on Capital Employed (ROCE) | 4.53% |
| Weighted Average Cost of Capital (WACC) | 7.22% |
| Revenue Per Employee | $339,097 |
| Profits Per Employee | $5,115 |
| Employee Count | 730 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 3.40 |
Taxes
In the past 12 months, MLAB has paid $10.33 million in taxes.
| Income Tax | 10.33M |
| Effective Tax Rate | 73.46% |
Stock Price Statistics
The stock price has decreased by -24.38% in the last 52 weeks. The beta is 0.88, so MLAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | -24.38% |
| 50-Day Moving Average | 86.46 |
| 200-Day Moving Average | 78.91 |
| Relative Strength Index (RSI) | 58.18 |
| Average Volume (20 Days) | 136,448 |
Short Selling Information
The latest short interest is 224,457, so 4.06% of the outstanding shares have been sold short.
| Short Interest | 224,457 |
| Short Previous Month | 223,687 |
| Short % of Shares Out | 4.06% |
| Short % of Float | 4.46% |
| Short Ratio (days to cover) | 1.77 |
Income Statement
In the last 12 months, MLAB had revenue of $247.54 million and earned $3.73 million in profits. Earnings per share was $0.68.
| Revenue | 247.54M |
| Gross Profit | 154.48M |
| Operating Income | 17.23M |
| Pretax Income | 14.07M |
| Net Income | 3.73M |
| EBITDA | 42.25M |
| EBIT | 17.23M |
| Earnings Per Share (EPS) | $0.68 |
Balance Sheet
The company has $30.47 million in cash and $170.02 million in debt, with a net cash position of -$139.55 million or -$25.26 per share.
| Cash & Cash Equivalents | 30.47M |
| Total Debt | 170.02M |
| Net Cash | -139.55M |
| Net Cash Per Share | -$25.26 |
| Equity (Book Value) | 186.69M |
| Book Value Per Share | 33.79 |
| Working Capital | 51.24M |
Cash Flow
In the last 12 months, operating cash flow was $41.53 million and capital expenditures -$3.59 million, giving a free cash flow of $37.94 million.
| Operating Cash Flow | 41.53M |
| Capital Expenditures | -3.59M |
| Depreciation & Amortization | 25.02M |
| Net Borrowing | -30.00M |
| Free Cash Flow | 37.94M |
| FCF Per Share | $6.87 |
Margins
Gross margin is 62.40%, with operating and profit margins of 6.96% and 1.51%.
| Gross Margin | 62.40% |
| Operating Margin | 6.96% |
| Pretax Margin | 5.68% |
| Profit Margin | 1.51% |
| EBITDA Margin | 17.07% |
| EBIT Margin | 6.96% |
| FCF Margin | 15.33% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 0.72%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 0.72% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 94.08% |
| Buyback Yield | -1.51% |
| Shareholder Yield | -0.80% |
| Earnings Yield | 0.74% |
| FCF Yield | 7.55% |
Analyst Forecast
The average price target for MLAB is $94.00, which is 5.86% higher than the current price. The consensus rating is "Hold".
| Price Target | $94.00 |
| Price Target Difference | 5.86% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MLAB has an Altman Z-Score of 1.55 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.55 |
| Piotroski F-Score | 6 |